191 related articles for article (PubMed ID: 36990671)
1. Electroconvulsive Seizure Normalizes Motor Deficits and Induces Autophagy Signaling in the MPTP-Induced Parkinson Disease Mouse Model.
Huh S; Yu HS; Kang N; Ahn YM; Kim YS; Kim SH
Psychiatry Investig; 2023 Mar; 20(3):273-283. PubMed ID: 36990671
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
4. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
[TBL] [Abstract][Full Text] [Related]
5. Electroconvulsive Seizures Induce Autophagy by Activating the AMPK Signaling Pathway in the Rat Frontal Cortex.
Kim SH; Yu HS; Park S; Park HG; Ahn YM; Kang UG; Kim YS
Int J Neuropsychopharmacol; 2020 Mar; 23(1):42-52. PubMed ID: 31678999
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
[TBL] [Abstract][Full Text] [Related]
7. Mitochonic acid 5 ameliorates the motor deficits in the MPTP-induced mouse Parkinson's disease model by AMPK-mediated autophagy.
Wan J; Gao Y; Tan J; Yi S; Huang K; Liu Y; Chang D; Xie J; Chen S; Wu H
Folia Neuropathol; 2022; 60(3):329-337. PubMed ID: 36382486
[TBL] [Abstract][Full Text] [Related]
8. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.
Su LY; Li H; Lv L; Feng YM; Li GD; Luo R; Zhou HJ; Lei XG; Ma L; Li JL; Xu L; Hu XT; Yao YG
Autophagy; 2015; 11(10):1745-59. PubMed ID: 26292069
[TBL] [Abstract][Full Text] [Related]
9. Anodal transcranial direct current stimulation prevents methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by modulating autophagy in an in vivo mouse model of Parkinson's disease.
Lee SB; Kim HT; Yang HO; Jang W
Sci Rep; 2018 Oct; 8(1):15165. PubMed ID: 30310174
[TBL] [Abstract][Full Text] [Related]
10. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y
Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.
Liu K; Shi N; Sun Y; Zhang T; Sun X
Neurochem Res; 2013 Jan; 38(1):201-7. PubMed ID: 23117422
[TBL] [Abstract][Full Text] [Related]
12. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
13. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex.
Kim SH; Yu HS; Huh S; Kang UG; Kim YS
Psychopharmacology (Berl); 2022 Feb; 239(2):443-454. PubMed ID: 34716784
[TBL] [Abstract][Full Text] [Related]
16. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.
Balke D; Tatenhorst L; Dambeck V; Ribas VT; Vahsen BF; Michel U; Bähr M; Lingor P
Mol Neurobiol; 2020 Feb; 57(2):685-697. PubMed ID: 31446549
[TBL] [Abstract][Full Text] [Related]
17. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
18. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
20. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
